Canopy Growth (FRA:11L) Tariff Resilience Score: 6/10 (As of Jul. 13, 2026)


FRA:11L Canopy Growth Corp FRA:11L
59 GF Score
Price €0.86
GF Value €0.66
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Canopy Growth Tariff Resilience Score?

Canopy Growth FRA:11L +0.09% 59 Tariff Resilience Score is 6 as of Jul. 13, 2026. GuruFocus rates FRA:11L with a GF Score™ of 59/100 and a GF Value™ of €0.66 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,029 Drug Manufacturers companies, Canopy Growth ranks better than 91.06% on this metric.

Canopy Growth has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Canopy Growth has Canopy Growth has a moderate exposure to tariffs due to its reliance on international markets for cannabis products. While it has diversified supply chains, its primary market is North America, which mitigates some risk. Historical tariff impacts have been minimal, and the company can leverage alternative suppliers and pricing strategies.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Canopy Growth might have Average Resilient.

Canopy Growth  (FRA:11L) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Canopy Growth Tariff Resilience Score Related Terms

FRA:11L vs ZTS, UTHR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canopy Growth Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Tariff Resilience Score falls into.


FRA:11L
59GF Score
Canopy Growth Corp FRA:11L
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Canopy Growth (FRA:11L) has a Tariff Resilience Score of 6 as of Jul. 13, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Canopy Growth ranks #92 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is Canopy Growth's Tariff Resilience Score too high?
Canopy Growth's current Tariff Resilience Score is 6. Based on the distribution chart, Canopy Growth ranks #92 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Canopy Growth has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Canopy Growth's Tariff Resilience Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Canopy Growth ranks #92 out of 1029 companies for Tariff Resilience Score. This places Canopy Growth in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Canopy Growth's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canopy Growth stock overvalued right now?
Based on GuruFocus' analysis, Canopy Growth (FRA:11L) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.66, compared to a current price of €0.86 — trading 29.7% above its estimated fair value. The current Tariff Resilience Score is 6. Canopy Growth's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Canopy Growth (FRA:11L), the current Tariff Resilience Score is 6 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Canopy Growth (FRA:11L) Overvalued in 2026?

Based on GuruFocus' analysis, Canopy Growth stock appears to be overvalued. The current stock price of €0.86 is trading 29.7% above its estimated GF Value™ of €0.66. GuruFocus considers Canopy Growth to be Modestly Overvalued.

Key valuation signals for FRA:11L:

  • Tariff Resilience Score: 6
  • GF Value™: €0.66 vs. price of €0.86 (29.7% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the FRA:11L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Canopy Growth Business Description

Address 1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
59GF Score

Get the complete analysis for FRA:11L

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€0.66
GF Value